Asia Pacific Biodefense Market- Segmentation, Market Share, Size, and Forecast to 2024

Asia Pacific Biodefense Market- Segmentation, Market Share, Size, and Forecast to 2024

SKU: 1317 Category:

This product is currently out of stock and unavailable.

  • Report Discription
  • Table of Content
  • Request for Sample

Biodefense is defined as the measures adopted to provide biosecurity to microorganisms which are at high risk of infectious disease or biological threats. The Asia Pacific biodefense market is anticipated to grow with CAGR of XX% during the forecasted period 2017-2024. Biodefense agents such as protozoan, bacterium, parasite, virus, fungus etc. are extensively deployed as biological weapons in bioterrorism and biological warfare. There is increased adoption of biodefense by the government organisations across the globe to minimise the threat of bioterrorism by deploying emergency medical units, decontamination units, hazardous materials etc. By deploying genetic engineering, there has been development of novel biological weapons by biological researchers that is highly efficient as compared to conventional counterparts and have overcome the technological limitations in adoption of pathogenic agents in military applications. Also, military combatant and civilian non combatant (combatant refers to troops in the field) are the target populations on which biodefense is applied. The major objective to adopt biodefense is to assimilate the sustained efforts of public health, law enforcement communities, homeland and national security, etc. However, as per OMICS International, increased biodefense and bioterrorism research that led to the development of effecient, powerful and cost effective methods of both protection and detection based biodefense strategies. Moreover, increased adoption of biodefense in Asia Pacific region have helped in fulfiling the requirement regarding the production of full-length, effective and immunogenic antibodies which would consists of human-like glycosylation patterns. Asia Pacific defense market is dominated by the presence of some key players such as Nanotherapeutics, Inc. Evogen Inc. etc. Bavarian Nordic, etc. Key strategies such as merger, acquisition, product launch are the strategic initiative taken by the key players to sustain in the dynamic market. For instance: in 2017, Emergent BioSolutions Inc. had completed the acquisition of Sanofi’s ACAM2000, small pox vaccine business, approved by the U.S. Food and Drug Administration (FDA) to enhance company’s market presence. In 2015, Nanotherapeutics, Inc. had completed the acquisition of biodefense program of XOMA Corporation for cost effective development and discovery of therapeutic antibodies. This strategic initiative was taken to increase the company’s portfolio. The growing investment in biotechnology is also injecting growth potential to the Asia Pacific biodefense market. Moreover, the increasing investment in research and development of biodefense technology and rising threat of potential biological warfare and bioterrorism is boosting the growth in the Asia Pacific biodefense market.

 

The global biodefense market is growing with a CAGR of XX% during forecast period. The growth in the global biodefense market is mainly driven by the increasing importance for disease surveillance mission to combat bioterrorism and increasing focus of public health services to identify bio-threat agents across the globe. The global biodefense market is valued at $XXX million in 2017 which is expected to reach to $XXX million by the end of 2024. The growth of global biodefensemarket is also influenced by the increased adoption of biotechnology, low cost production of biological defense agents and rising threat of potential biological warfare. As compared to global market, the Asia Pacific market is growing with a high CAGR of XXX% during forecast period. Asia Pacific region have huge growth potential due to rising research and development activity for the development of new biodefense weapons in the Asia Pacific region.

 

The Asia Pacific biodefense market is segmented on the basis of product. The product segment is mainly segmented into anthrax, botulism, radiation/nuclear defense, smallpox, and others. Anthrax is the leading product segment due to increasing focus of leading market players to improve the product portfolio for anthrax prevention. Furthermore, increasing supportive government funding for the production of vaccines for prevention of anthrax such as Joint Program Executive Office for Chemical and Biological Defense, Biomedical Advanced Research and Development Authority (BARDA), BioShield Legislation has led to novel opportunities for anthrax segment. Whereas, others products segment (including Ebola, tularemia, glanders, etc.) is expected to emerge as the fastest growing segment owing to rising prevalence of viral hemorrhagic fever that led to development of biodefense products to prevent these conditions.

 

The Asia Pacific biodefense market is geographically divided into India, China, Japan, Korea, and others. China held the largest market share in the Asia Pacific region. Growth in China biodefense market is mainly driven by the growing pharmaceutical industry, increasing biodefense investments. As per International Trade Administration, China is the second largest pharmaceutical market in the world. The china pharmaceutical industry is forecasted to grow from $108 billion in 2015 to $167 billion by 2020, thereby representing an annual growth rate of 9.1%.However, India is expected to emerge as the fastest growing market region for APAC biodefense market during the forecast period 2017-2024. The growth in India biodefense market is mainly attributed by the increasing military and defense expenditure, growing awareness regarding bioterrorism and biological warfare which has led to increased adoption of biodefense products.

  1. INTRODUCTION
    • EXECUTIVE SUMMARY
    • ESTIMATION METHODOLOGY
  2. MARKET OVERVIEW
    • MARKET DEFINITION AND SCOPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • PORTERS 5 FORCE MODEL
    • KEY MARKET TRENDS
      • PIPELINE ANALYSIS
      • R & D SCENARIO
      • REGULATORY FRAMEWORK
    • PARAMETRIC ANALYSIS
    • KEY MARKET INSIGHTS
      • TOP 3 EMERGING COUNTRIES
      • TOP 3 REVENUE GENERATING SEGMENTS
      • TOP 3 EMERGING SEGMENTS
    • COMPETITIVE INTELLIGENCE
      • MARKET SHARE ANALYSIS
      • TOP WINNING STRATEGIES
      • CASE STUDY: TOP COMPETITIVE MOVES
    • STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
      • INVESTMENT OPPORTUNITIES BY REGIONS
      • OPPORTUNITIES IN EMERGING APPLICATIONS
      • INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
  1. MARKET DETERMINANTS
    • MARKET DRIVER
      • INCREASING IMPORTANCE FOR DISEASE SURVEILLANCE
      • INCREASING FOCUS OF PUBLIC HEALTH SERVICES
      • INCREASED ADOPTION OF BIOTECHNOLOGY
      • LOW COST PRODUCTION OF BIOLOGICAL DEFENSE AGENTS
      • RISING THREAT OF POTENTIAL BIOLOGICAL WARFARE
    • MARKET RESTRAINTS
      • NEGATIVE IMPACT ON HEALTH
    • MARKET OPPORTUNITIES
      • ADVANCEMENTS IN BIODEFENSE
      • INCREASING GOVERNMENT INVESTMENT AND PROGRAMS FOR BIODEFENSE
      • INCREASING MILITARY AND DEFENCE EXPENDITURE
    • MARKET CHALLENGES
      • ETHICAL CHALLENGES IN BIODEFENSE
  1. MARKET SEGMENTATION
    • APAC BIODEFENSE MARKET BY PRODUCT 2015-2024 ($ MILLION)
      • APAC BIODEFENSE MARKET BY ANTHRAX 2015-2024 ($ MILLION)
      • APAC BIODEFENSE MARKET BY SMALLPOX 2015-2024 ($ MILLION)
      • APAC BIODEFENSE MARKET BY BOTULISM 2015-2024 ($ MILLION)
      • APAC BIODEFENSE MARKET BY RADIATION/NUCLEAR DEFENSE 2015-2024 ($ MILLION)
      • APAC BIODEFENSE MARKET BY OTHERS 2015-2024 ($ MILLION)
  1. Global Level Segmentation
    • CHINA BIODEFENSE MARKET 2015-2024 ($ MILLION)
    • INDIA BIODEFENSE MARKET2015-2024 ($ MILLION)
    • KOREA BIODEFENSE MARKET2015-2024 ($ MILLION)
    • JAPAN BIODEFENSE MARKET2015-2024 ($ MILLION)
    • AUSTRALIA BIODEFENSE MARKET2015-2024 ($ MILLION)
    • THAILAND BIODEFENSE MARKET2015-2024 ($ MILLION)
    • REST OF ASIA PACIFIC BIODEFENSE MARKET2015-2024 ($ MILLION)
  2. GLOBAL VS APAC MARKET “A COMPARATIVE STUDY”
    • DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • OPPORTUNITY MATRIX
    • US VS APAC MARKET
    • EUROPE VS APAC MARKET
    • ROW VS APAC MARKET
  3. COMPANY PROFILES
    • ACAMBIS PLC (UK)
    • ACHAOGEN (U.S)
    • AEOLUS PHARMACEUTICALS (AOLS) (U.S.)
    • ALNYLAM PHARMACEUTICALS (U.S.)
    • BAVARIAN NORDIC (DENMARK)
    • CLEVELAND BIOLABS, INC. (U.S.)
    • DYNAVAX TECHNOLOGIES INC. (U.S.)
    • DYNPORT VACCINE COMPANY LLC (U.S.)
    • ELUSYS THERAPEUTICS (U.S.)
    • EMERGENT BIOSOLUTIONS (U.S.)
    • EVOGEN INC. (U.S.)
    • HUMAN GENOME SCIENCES (U.S.)
    • ICHOR MEDICAL SYSTEMS INC. (U.S.)
    • NANOTHERAPEUTICS, INC. (U.S.)
    • SIGA TECHNOLOGIES (U.S.)

 

LIST OF TABLES

  1. APAC BIODEFENSE MARKET BY PRODUCT 2015-2024 ($ MILLION)
  2. APAC BIODEFENSE MARKET BY ANTHRAX ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  3. APAC BIODEFENSE MARKET BY SMALLPOX ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  4. APAC BIODEFENSE MARKET BY BOTULISM ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  5. APAC BIODEFENSE MARKET BY RADIATION/NUCLEAR DEFENSE ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  6. APAC BIODEFENSE MARKET BY OTHERS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  7. NORTH AMERICA BIODEFENSE MARKET 2015-2024 ($ MILLION)
  8. EUROPE BIODEFENSE MARKET 2015-2024 ($ MILLION)
  9. ASIA PACIFIC BIODEFENSE MARKET 2015-2024 ($ MILLION)
  10. REST OF THE WORLD BIODEFENSE MARKET 2015-2024 ($ MILLION)
  11. NORTH AMERICA BIODEFENSE MARKET BY PRODUCT 2015-2024 ($ MILLION)
  12. EUROPE BIODEFENSE MARKET BY PRODUCT 2015-2024 ($ MILLION)
  13. APAC BIODEFENSE MARKET BY PRODUCT 2015-2024 ($ MILLION)
  14. REST OF THE WORLD BIODEFENSE MARKET BY PRODUCT 2015-2024 ($ MILLION)
  15. APAC BIODEFENSE MARKET BY COUNTRIES 2015-2024 ($ MILLION)
  16. CHINA BIODEFENSE MARKET BY PRODUCT 2015-2024 ($ MILLION)
  17. INDIA BIODEFENSE MARKETBY PRODUCT 2015-2024 ($ MILLION)
  18. KOREA BIODEFENSE MARKETBY PRODUCT 2015-2024 ($ MILLION)
  19. JAPAN BIODEFENSE MARKETBY PRODUCT 2015-2024 ($ MILLION)
  20. AUSTRALIA BIODEFENSE MARKETBY PRODUCT 2015-2024 ($ MILLION)
  21. THAILAND BIODEFENSE MARKETBY PRODUCT 2015-2024 ($ MILLION)
  22. REST OF ASIA PACIFIC BIODEFENSE MARKETBY PRODUCT 2015-2024 ($ MILLION)
  23. GLOBALBIODEFENSE MARKET BY PRODUCT 2015-2024 ($ MILLION)
  24. GLOBAL ANTHRAX MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  25. GLOBAL SMALLPOX MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  26. GLOBAL BOTULISM MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  27. GLOBAL RADIATION/NUCLEAR DEFENSE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  28. GLOBAL OTHERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  29. DRIVER IMPACT ANALYSIS IN GLOBAL BIODEFENSE MARKET
  30. RESTRAINTS IMPACT ANALYSIS IN GLOBAL BIODEFENSEMARKET
  31. OPPORTUNITY IMPACT ANALYSIS IN GLOBAL BIODEFENSEMARKET
  32. CHALLENGES IMPACT ANALYSIS IN GLOBAL BIODEFENSEMARKET
  33. REGULATORY FRAMEWORK IN GLOBAL BIODEFENSE MARKET

LIST OF FIGURE

  1. APAC BIODEFENSE MARKET BY ANTHRAX 2015-2024 ($ MILLION)
  2. APAC BIODEFENSE MARKET BY SMALLPOX 2015-2024 ($ MILLION)
  3. APAC BIODEFENSE MARKET BY BOTULISM 2015-2024 ($ MILLION)
  4. APAC BIODEFENSE MARKET BY RADIATION/NUCLEAR DEFENSE 2015-2024 ($ MILLION)
  5. APAC BIODEFENSE MARKET BY OTHERS 2015-2024 ($ MILLION)
  6. CHINA BIODEFENSE MARKET 2015-2024 ($ MILLION)
  7. INDIA BIODEFENSE MARKET2015-2024 ($ MILLION)
  8. KOREA BIODEFENSE MARKET2015-2024 ($ MILLION)
  9. JAPAN BIODEFENSE MARKET2015-2024 ($ MILLION)
  10. AUSTRALIA BIODEFENSE MARKET2015-2024 ($ MILLION)
  11. THAILAND BIODEFENSE MARKET2015-2024 ($ MILLION)
  12. REST OF ASIA PACIFIC BIODEFENSE MARKET2015-2024 ($ MILLION)

 

 

Name

Email

Phone

Company Name

Country

Report Title